Eleven-year follow-up data continue to show the invasive disease-free survival benefit for node-positive patients seen in previous analyses.

Q1 2025 Earnings Conference Call May 16, 2025 3:30 PM ETCompany ParticipantsSalah Gamoudi - CFODavid Park - CEO ...

This advertisement has not loaded yet, but your article continues below. Many agencies and groups in the community are gearing up for summer programs and events. Volunteers are the key to success ...

Oncology DMPK, Oncology R&D, AstraZeneca, Cambridge CB2 0AA, U.K.